Accessibility Menu
 
Liquidia logo

Liquidia

(NASDAQ) LQDA

Current Price$37.69
Market Cap$3.32B
Since IPO (2018)+256%
5 Year+1,203%
1 Year+174%
1 Month+3%

Liquidia Financials at a Glance

Market Cap

$3.32B

Revenue (TTM)

$158.32M

Net Income (TTM)

$68.92M

EPS (TTM)

$-0.83

P/E Ratio

-45.28

Dividend

$0.00

Beta (Volatility)

0.99 (Low)

Price

$37.69

Volume

0

Open

$39.23

Previous Close

$37.69

Daily Range

$37.09 - $39.80

52-Week Range

$11.85 - $46.67

LQDA: Motley Fool Moneyball Superscore

65

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Liquidia

Industry

Pharmaceuticals

Employees

216

CEO

Roger A. Jeffs, PhD

Headquarters

Morrisville, NC 27560, US

LQDA Financials

Key Financial Metrics (TTM)

Gross Margin

97%

Operating Margin

-32%

Net Income Margin

-44%

Return on Equity

-113%

Return on Capital

-27%

Return on Assets

-21%

Earnings Yield

-2.21%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.32B

Shares Outstanding

88.11M

Volume

0

Short Interest

0.00%

Avg. Volume

1.58M

Financials (TTM)

Gross Profit

$153.90M

Operating Income

$51.38M

EBITDA

$49.85M

Operating Cash Flow

$35.69M

Capital Expenditure

$4.34M

Free Cash Flow

$40.02M

Cash & ST Invst.

$190.68M

Total Debt

$197.93M

Liquidia Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$92.02M

+3054.6%

Gross Profit

$93.58M

+5887.5%

Gross Margin

1.02%

N/A

Market Cap

$3.32B

N/A

Market Cap/Employee

$19.52M

N/A

Employees

170

N/A

Net Income

$14.55M

+137.9%

EBITDA

$20.11M

+160.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$7.25M

-113.4%

Accounts Receivable

$54.09M

+1889.4%

Inventory

$0.00

-100.0%

Long Term Debt

$139.03M

+33.7%

Short Term Debt

$58.89M

+219.5%

Return on Assets

-21.02%

N/A

Return on Invested Capital

-26.74%

N/A

Free Cash Flow

$42.21M

+264.9%

Operating Cash Flow

$44.24M

+312.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DNLIDenali Therapeutics Inc.
$20.54-0.15%
GPCRStructure Therapeutics Inc.
$48.22-4.99%
RCUSArcus Biosciences, Inc.
$22.74-6.23%
ETNB89bio, Inc.
$14.84+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.29-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$58.08-0.01%
PBMPsyence Biomedical
$11.30+0.49%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$56.91+0.01%

Questions About LQDA

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.